Research Topics
Species | C RenouSummaryCountry: France Publications
| Collaborators
|
Detail Information
Publications
Hepatitis E virus in HIV-infected patientsChristophe Renou
Hôpital de jour, Centre Hospitalier, Hyeres, France
AIDS 24:1493-9. 2010..Although a potential risk of chronicity exists in HIV-infected patients, no survey has been conducted in this population. The aim of this study was to assess the sero-virological prevalence of HEV in French HIV-infected patients...
Histological features and HLA class II alleles in hepatitis C virus chronically infected patients with persistently normal alanine aminotransferase levelsC Renou
Unité d Hépato Gastroentérologie, CH Hyéres, France
Gut 51:585-90. 2002....
[How to investigate and diagnose autochthonous hepatitis E?]C Renou
Hôpital de jour, centre hospitalier de Hyères, rue du Maréchal Juin, Hyeres, France
Gastroenterol Clin Biol 33:F27-35. 2009..Lastly, HEV infection may be a cause of chronic hepatitis in immunocompromised patients (mostly in solid organ-transplant recipients) which can evolve to cirrhosis...
Adefovir combined with hepatitis C virus treatment may prevent hepatitis B reactivation after hepatitis C virus eradication in hepatitis B and C virus carriersChristophe Renou
Gastroenterology Department, Hyères Hospital, Hyeres, France
Eur J Gastroenterol Hepatol 20:1235-7. 2008..This finding raises the question as to whether preemptive HBV treatment should be prescribed along with HCV treatment to prevent HBV from being reactive after HCV eradication in coinfected HBV/HCV patients...
A national survey of acute hepatitis E in FranceC Renou
Hôpital de jour, Hôpital d Hyères, BP 82, 83407 Hyères Cedex, France
Aliment Pharmacol Ther 27:1086-93. 2008..Few data are available on the incidence, risk factors and contamination pathways involved in acute indigenous hepatitis E in developed countries...
Treatment of chronic hepatitis C with pegylated interferon and ribavirin in treatment-naive patients in 'true life': a plea in favor of independent postmarketing evaluationsAlexandre Pariente
Unité d hépatogastroentérologie, Centre Hospitalier, Pau Cedex, France
Eur J Gastroenterol Hepatol 22:1297-302. 2010..Results of treatments for chronic hepatitis C virus are only estimated and disclosed from pivotal trials...
Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsiesM Bourliere
Department of Hepato-Gastroenterology, Saint-Joseph Hospital, Marseille, France
J Viral Hepat 13:659-70. 2006..The combination of all tests without liver biopsy allowed 191/235 (81.3%) patients to be correctly classified; liver biopsy remained mandatory in some patients (18.7%)...
Multicentre study of hepatitis B virus genotypes in France: correlation with liver fibrosis and hepatitis B e antigen statusP Halfon
Alphabio Laboratory, Marseille, France
J Viral Hepat 13:329-35. 2006..Genotype A was associated with HBeAg positivity and genotype D with HBe antibody positivity. In our European patients, we find no clear association between a given HBV genotype and liver disease severity...
Coeliac disease in chronic hepatitis C: a French multicentre prospective studyT Thevenot
Service d Hépatologie et de Soins Intensifs Digestifs, Hôpital Universitaire Jean Minjoz, Besancon, France
Aliment Pharmacol Ther 26:1209-16. 2007..A prevalence of 1.2% of coeliac disease (CD) in patients with chronic hepatitis C was recently reported, suggesting a possible epidemiological link between these two diseases. However, other studies have not found this relationship...
Effect of ondansetron, a 5-HT3 receptor antagonist, on fatigue in chronic hepatitis C: a randomised, double blind, placebo controlled studyT Piche
Department of Hepatogastroenterology, CHU de Nice, France
Gut 54:1169-73. 2005..In this randomised, placebo controlled, double blind trial, we investigated the effect of orally administered ondansetron on fatigue in CHC...
High-risk behavior and sexual transmission of hepatitis CC Renou
Am J Gastroenterol 100:246-7; author reply 247-8. 2005
Severe neutropenia and post-hepatitis C cirrhosis treatment: is interferon dose adaptation at once necessary?C Renou
Am J Gastroenterol 97:1260-3. 2002
Influence of HLA-DR phenotype on the risk of hepatitis C virus-associated mixed cryoglobulinemiaP Cacoub
Department of Internal Medicine, , Paris, France
Arthritis Rheum 44:2118-24. 2001..In contrast, HLA-DR7 appears to protect against the production of type II MC. These results suggest that the host's immune response genes may play a role in the pathogenesis of HCV-associated MC...
